Connection

Co-Authors

This is a "connection" page, showing publications co-authored by MARTIN MATZUK and MILTON FINEGOLD.
Connection Strength

0.291
  1. Transgenic models to study the roles of inhibins and activins in reproduction, oncogenesis, and development. Recent Prog Horm Res. 1996; 51:123-54; discussion 155-7.
    View in: PubMed
    Score: 0.135
  2. Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice. Mol Endocrinol. 1996 May; 10(5):534-43.
    View in: PubMed
    Score: 0.035
  3. Synergistic effects of inhibins and m?llerian-inhibiting substance on testicular tumorigenesis. Mol Endocrinol. 1995 Oct; 9(10):1337-45.
    View in: PubMed
    Score: 0.033
  4. Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc Natl Acad Sci U S A. 1994 Sep 13; 91(19):8817-21.
    View in: PubMed
    Score: 0.031
  5. Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature. 1992 Nov 26; 360(6402):313-9.
    View in: PubMed
    Score: 0.027
  6. Fatty acid synthesis is essential in embryonic development: fatty acid synthase null mutants and most of the heterozygotes die in utero. Proc Natl Acad Sci U S A. 2003 May 27; 100(11):6358-63.
    View in: PubMed
    Score: 0.014
  7. Genetic analysis of the M?llerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev. 1996 Oct 15; 10(20):2577-87.
    View in: PubMed
    Score: 0.009
  8. Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor. Mol Endocrinol. 1994 Aug; 8(8):983-95.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.